AMCP Comments on House Passage of 21st Century Cures Act
H.R. 6 would increase funding for FDA and NIH, and includes provision to prevent Rx drug abuse of opioids among at-risk Medicare beneficiaries.
Registration is open! AMCP Nexus 2015
Mark your calendars: AMCP Nexus 2015 takes place Monday-Thursday, Oct. 26-29 in Orlando, Fla. Registration is now open! See you there.
August 2015 Issue of JMCP is Now Available
Current issue includes research on factors associated with failure to achieve SVR in Hepatitis C Genotype 3 patients within an integrated care delivery system.
AMCP Comments on U.S. Supreme Court’s Ruling in King vs. Burwell
AMCP CEO Edith A. Rosato, RPh, IOM, issued a statement on the U.S. Supreme Court’s June 25 ruling in King vs. Burwell and its effect on patients covered under the Affordable Care Act.
AMCP Convenes Experts to Discuss Biosimilars
AMCP convened a group of health care thought leaders from across the country to discuss issues surrounding the marketplace readiness, acceptance and utilization of biosimilars.
New York Times Publishes AMCP Letter
The New York Times published a letter from AMCP CEO Edith A. Rosato, RPh, IOM, objecting to the newspaper’s May 5 editorial supporting government price negotiations of pharmaceuticals.